Cell line modeling for systems medicine in cancers (Review)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Nayoung | - |
dc.contributor.author | He, Ningning | - |
dc.contributor.author | Yoon, Sukjoon | - |
dc.date.available | 2021-02-22T12:01:20Z | - |
dc.date.issued | 2014-02 | - |
dc.identifier.issn | 1019-6439 | - |
dc.identifier.issn | 1791-2423 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/10992 | - |
dc.description.abstract | Unexpected drug efficacy or resistance is poorly understood in cancers because of the lack of systematic analyses of drug response profiles in cancer tissues of various genotypic backgrounds. The recent development of high-throughput technologies has allowed massive screening of chemicals and drugs against panels of heterogeneous cancer cell lines. In parallel, multi-level omics datasets, including genome-wide genetic alterations, gene expression and protein regulation, have been generated from diverse sets of cancer cell lines, thus providing a surrogate system, known as cancer cell line modeling, that can represent cancer diversity. Taken together, recent efforts with cancer cell line modeling have enabled a systematic understanding of the causal factors of varied drug responses in cancers. These large-scale association studies could potentially predict and optimize target windows for drug treatment in cancer patients. The present review provides an overview of the major types of cell line-based large datasets and their applications in cancer studies. Moreover, this review discusses recent integrated approaches that use multi-level datasets to discover synergistic drug combination or repositioning for cancer treatment. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | SPANDIDOS PUBL LTD | - |
dc.title | Cell line modeling for systems medicine in cancers (Review) | - |
dc.type | Article | - |
dc.publisher.location | 그리이스 | - |
dc.identifier.doi | 10.3892/ijo.2013.2202 | - |
dc.identifier.scopusid | 2-s2.0-84894485405 | - |
dc.identifier.wosid | 000332687400003 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF ONCOLOGY, v.44, no.2, pp 371 - 376 | - |
dc.citation.title | INTERNATIONAL JOURNAL OF ONCOLOGY | - |
dc.citation.volume | 44 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 371 | - |
dc.citation.endPage | 376 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | DNA COPY NUMBER | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | SENSITIVITY | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | MUTATIONS | - |
dc.subject.keywordPlus | PATTERNS | - |
dc.subject.keywordPlus | DATABASE | - |
dc.subject.keywordPlus | GENOME | - |
dc.subject.keywordPlus | DRUGS | - |
dc.subject.keywordAuthor | NCI60 | - |
dc.subject.keywordAuthor | systems medicine | - |
dc.subject.keywordAuthor | drug sensitivity | - |
dc.subject.keywordAuthor | cancer cell line modeling | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.